PMC2931395_01
Screening MR images: (a) coronal T2-weighted image showing two fibroids, (b) coronal T1-weighted contrast-enhanced image:the right fibroid is already nonenhancing, whereas the left one is still viable.
OGI2010-351273.001.jpg
PMC2931395_01_OGI2010-351273.001.jpg
fig1
Two intramural fibroids were observed (Figure 1).
MR angiography. The reason for UAE unsuitability: (a) narrow left uterine artery, (b) no obvious right uterine artery.
OGI2010-351273.002.jpg
PMC2931395_01_OGI2010-351273.002.jpg
fig2
The left fibroid was supplied only by the narrow left uterine artery (Figure 2).
Treatment images: (a) Sagittal T2-weighted planning image, (b) Sagittal contrast-enhanced T1-weighted posttreatment image showing 90% of nonenhancing volume on the left fibroid.
OGI2010-351273.003.jpg
PMC2931395_01_OGI2010-351273.003.jpg
fig3
T1-weighted contrast-enhanced images that were obtained immediately following the procedure showed a nonperfused volume (NPV) of 81 cc, which constitutes approximately 90% of the fibroid volume (Figure 3).
Coronal T2-weighted image three months post-treatment, showing 49% volume shrinkage of the treated fibroid.
OGI2010-351273.004.jpg
PMC2931395_01_OGI2010-351273.004.jpg
fig4
T1-weighted and T2-weighted MR images, obtained at that time, revealed shrinkage of the treated fibroid by 49% (Figure 4). The patient's SSS was 22, reflecting a 25-point decrease from the base-line score before the MRgFUS treatment.